Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Episode 15 with Professor Ludwig Kappos on the DECIDE trial of daclizumab versus interferon ë_-1a
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
Episode 14 with Professor Gavin Giovannoni on the Epstein-Barr Virus (EBV).
JOINT CONGRESS OF EUROPEAN NEUROLOGY
Social Media Representation of Chronic Cerebrospinal Venous Insufficiency Intervention for Multiple Sclerosis.
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis.
AAN: Annual Meeting On Demand Encore: Treatment Optimization for Relapsing MS
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.
Differing trends in the incidence of vascular comorbidity in MS and the general population.
Multiple sclerosis and risk of attempted and completed suicide - a cohort study.
Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis.
Mast cell inflammasome activity in the meninges regulates EAE disease severity.
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study.
JC polyomavirus mutants escape antibody-mediated neutralization.
Individual Neuronal Subtypes Exhibit Diversity in CNS Myelination Mediated by Synaptic Vesicle Release.
Contribution of different relapse phenotypes to disability in multiple sclerosis.
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.
Immuno-modulatory Properties of a Quinolin-2-(1H)-on-3-carboxamide Derivative: Relevance in Multiple Sclerosis.
Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study.
CCL genes in multiple sclerosis and systemic lupus erythematosus.
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis.
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
Neuroscience: Improving Translation of Animal Models for Nervous System Disorders: A Workshop

Pages